Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Clinical trial NCT05666128 · COMPLETED
Trial details
- NCT number
- NCT05666128
- Sponsor
- Hyundai Pharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2023-06-28
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.